RxDoctor Payments DataLook up a doctor →

Pearl Kwong, MD

Pediatric Dermatology · Jacksonville, FLNPI 1043309909

Payments from drug & device makers

$7,971,162in general payments, 2019–2025

Across 4,424 payments — averaging $1801.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.5M
  • Eli Lilly$1.4M
  • Amgen$755K
  • Regeneron Healthcare Solutions, Inc.$578K
  • Pfizer$528K
  • AbbVie$520K
  • plus $2.7M from 43 others
$55,202in research payments, 2019–2025

Across 17 payments — averaging $3247.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$27K
  • Almirall LLC$18K
  • Novartis$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few pediatric dermatology providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$4,033
Medicare patients
13
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric dermatology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →